Modalis Therapeutics Corporation (4883.T)

JPY 103.0

(-1.9%)

Total Liabilities Summary of Modalis Therapeutics Corporation

  • Modalis Therapeutics Corporation's latest annual total liabilities in 2023 was 645.5 Million JPY , up 242.26% from previous year.
  • Modalis Therapeutics Corporation's latest quarterly total liabilities in 2024 Q2 was 296.94 Million JPY , down -45.76% from previous quarter.
  • Modalis Therapeutics Corporation reported annual total liabilities of 188.6 Million JPY in 2022, down -63.73% from previous year.
  • Modalis Therapeutics Corporation reported annual total liabilities of 519.92 Million JPY in 2021, up 641.07% from previous year.
  • Modalis Therapeutics Corporation reported quarterly total liabilities of 296.94 Million JPY for 2024 Q2, down -45.76% from previous quarter.
  • Modalis Therapeutics Corporation reported quarterly total liabilities of 645.5 Million JPY for 2023 FY, up 242.26% from previous quarter.

Annual Total Liabilities Chart of Modalis Therapeutics Corporation (2023 - 2019)

Historical Annual Total Liabilities of Modalis Therapeutics Corporation (2023 - 2019)

Year Total Liabilities Total Liabilities Growth
2023 645.5 Million JPY 242.26%
2022 188.6 Million JPY -63.73%
2021 519.92 Million JPY 641.07%
2020 70.15 Million JPY 362.52%
2019 15.16 Million JPY 0.0%

Peer Total Liabilities Comparison of Modalis Therapeutics Corporation

Name Total Liabilities Total Liabilities Difference
Pharma Foods International Co., Ltd. 24.98 Billion JPY 97.417%
Takeda Pharmaceutical Company Limited 7834.78 Billion JPY 99.992%
Sumitomo Pharma Co., Ltd. 751.37 Billion JPY 99.914%
Shionogi & Co., Ltd. 164.35 Billion JPY 99.607%
Wakamoto Pharmaceutical Co.,Ltd. 3.39 Billion JPY 80.987%
Nippon Shinyaku Co., Ltd. 42.86 Billion JPY 98.494%
Kaken Pharmaceutical Co., Ltd. 27.86 Billion JPY 97.684%
Eisai Co., Ltd. 494.82 Billion JPY 99.87%
Morishita Jintan Co., Ltd. 5.04 Billion JPY 87.192%
Hisamitsu Pharmaceutical Co., Inc. 61.69 Billion JPY 98.954%
Mochida Pharmaceutical Co., Ltd. 30.83 Billion JPY 97.906%
Fuso Pharmaceutical Industries,Ltd. 39.79 Billion JPY 98.378%
Nippon Chemiphar Co., Ltd. 31.08 Billion JPY 97.923%
Tsumura & Co. 132.88 Billion JPY 99.514%
Kissei Pharmaceutical Co., Ltd. 39.79 Billion JPY 98.378%
Torii Pharmaceutical Co., Ltd. 13.29 Billion JPY 95.145%
Towa Pharmaceutical Co., Ltd. 274.75 Billion JPY 99.765%
Fuji Pharma Co., Ltd. 44.15 Billion JPY 98.538%
Zeria Pharmaceutical Co., Ltd. 70.7 Billion JPY 99.087%
KYORIN Holdings, Inc. 46.89 Billion JPY 98.623%
Taiko Pharmaceutical Co.,Ltd. 7 Billion JPY 90.782%
Daito Pharmaceutical Co.,Ltd. 25.43 Billion JPY 97.463%
SymBio Pharmaceuticals Limited 8.14 Billion JPY 92.072%
MedRx Co., Ltd 129 Million JPY -400.39%
Mizuho Medy Co.,Ltd. 3.27 Billion JPY 80.275%
Solasia Pharma K.K. 673 Million JPY 4.086%
ASKA Pharmaceutical Holdings Co.,Ltd. 31.38 Billion JPY 97.943%
Sawai Group Holdings Co., Ltd. 163.99 Billion JPY 99.606%
Cyfuse Biomedical K.K. 1.01 Billion JPY 36.173%
Toho Holdings Co., Ltd. 523.98 Billion JPY 99.877%
Koa Shoji Holdings Co.,Ltd. 6.95 Billion JPY 90.715%